1.1 Articolo in rivista

1.1 Articolo in rivista: [39368] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 12.461 a 12.480 di 39.368

Second-line therapy in advanced biliary tract cancer: What should be the standard?

2013-01-01 Cereda, S; Belli, C; Rognone, A; Mazza, E; Reni, M

A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands

2004-01-01 Martins, C; Cavaco, B; Tonon, G; Kaye, Fj; Soares, J; Fonseca, I

Current therapeutic approaches to primary CNS lymphoma

2003-01-01 Ferreri, Ajm; Dell’Oro, S; Reni, M

The AP-1 transcription factor JunB promotes multiple myeloma cell proliferation, survival and drug resistance in the bone marrow microenvironment

2016-01-01 Fan, ; Fengjuan, ; Vallet, ; Sonia, ; Bashari, ; Muhammad, Hasan; Jarahian, ; Mostafa, ; Morelli, ; Eugenio, ; Hose, ; Dirk, ; Bakiri, ; Latifa, ; Ball, ; Claudia, ; Glimm, ; Hanno, ; Sattler, ; Martin, ; Goldschmidt, ; Hartmut, ; Tonon, G; Tassone, ; Pierfrancesco, ; Wagner, ; Erwin, F.; Jager, ; Dirk, ; Podar, ; Klaus,

Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets?

2015-01-01 Brunetti, ; Russo, ; Scarpa, ; Santini, ; Reni, M; Bittoni, ; Azzariti, ; Aprile, ; Delcuratolo, ; Signorile, ; Gnoni, ; Palermo, ; Lorusso, ; Cascinu, ; Silvestris,

Awakening the Hippo co-activator YAP1, a mercurial cancer gene, in hematologic cancers

2014-01-01 Cottini, ; Francesca, ; Anderson, ; Kenneth, C; Tonon, G

Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide

2005-01-01 Brada, M; Ashley, S; Dowe, A; Gonsalves, A; Huchet, A; Pesce, G; Reni, M; Saran, F; Wharram, B; Wilkins, M; Wilkins, P

Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients

2016-01-01 Calura, ; Enrica, ; Bisognin, ; Andrea, ; Manzoni, ; Martina, ; Todoerti, ; Katia, ; Taiana, ; Elisa, ; Sales, ; Gabriele, ; Morgan, ; Gareth, J.; Tonon, G; Amodio, ; Nicola, ; Tassone, ; Pierfrancesco, ; Neri, ; Antonino, ; Agnelli, ; Luca, ; Romualdi, ; Chiara, ; Bortoluzzi, ; Stefania,

Quality control by portal film analysis in radiotherapy for prostate cancer: A comparison between two different institutions and treatment techniques

1998-01-01 Italia, C; Fiorino, C; Ciocca, M; Cattaneo, Gm; Montanaro, P; Bolognesi, A; Lanceni, A; Reni, M; Bonini, A; Modugno, A; Calandrino, R; Valdagni, R

The small- molecule VEGF- receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma

2006-01-01 Podar, K; Tonon, G; Sattler, M; Catley, Lp; Tai, Yt; Yasui, H; Legouill, S; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc

Guidelines for the treatment of primary central nervous system lymphomas in immunocompetent patients

2003-01-01 Ferreri, Ajm; Dell’Oro, S; Reni, M

Spectral karyotyping combined with locus-specific FISH simultaneously defines genes and chromosomes involved in chromosomal translocations.

2000-01-01 Tonon, G; Roschke, A; Stover, K; Shou, Y; Kuehl, Wm; Kirsch, Ir

Neoadjuvant therapy in resectable pancreatic cancer: A critical review

2013-01-01 Belli, C; Cereda, S; Anand, S; Reni, M

Karyotypic "state" as a potential determinant for anticancer drug discovery.

2005-01-01 Roschke, Av; Lababidi, S; Tonon, G; Gehlhaus, Ks; Bussey, K; Weinstein, Jn; Kirsch, Ir

Primary CNS lymphomas prognosis

2007-01-01 Ferreri, Ajm; Reni, M; Zucca, E; Cavalli, F

UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition

2017-01-01 Ezponda, ; Teresa, ; Dupere-Richer, ; Daphne, ; Will, ; Christine, M.; Small, ; Eliza, C.; Varghese, ; Nobish, ; Patel, ; Tej, ; Nabet, ; Behnam, ; Popovic, ; Relja, ; Oyer, ; Jon, ; Bulic, ; Marinka, ; Zheng, ; Yupeng, ; Huang, ; Xiaoxiao, ; Shah, ; Mrinal, Y.; Maji, ; Sayantan, ; Riva, ; Alberto, ; Occhionorelli, ; Manuela, ; Tonon, G; Kelleher, ; Neil, ; Keats, ; Jonathan, ; Licht, ; Jonathan, D.

Second line treatment for primary central nervous system lymphoma

1999-01-01 Reni, M; Ferreri, Ajm; Villa, E

Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells.

2001-01-01 Greco, Nj; Tonon, G; Chen, W; Luo, X; Dalal, R; Jamieson, Ga

High resolution genomic profiles of human lung cancer.

2005-01-01 Tonon, G; Wong, Kk; Maulik, G; Brennan, C; Feng, B; Zhang, Y; Khatry, Db; Protopopov, A; You, Mj; Aguirre, Aj; Martin, Es; Yang, Z; Ji, H; Chin, L; Depinho, Ra.

The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications.

2011-01-01 Podar, K; Zimmerhackl, A; Fulciniti, M; Tonon, G; Hainz, U; Tai, Yt; Vallet, S; Halama, N; Jäger, D; Olson, Dl; Sattler, M; Chauhan, D; Anderson, Kc.

Titolo	Data di pubblicazione	Autore(i)
Second-line therapy in advanced biliary tract cancer: What should be the standard?	1-gen-2013	Cereda, S; Belli, C; Rognone, A; Mazza, E; Reni, M
A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands	1-gen-2004	Martins, C; Cavaco, B; Tonon, G; Kaye, Fj; Soares, J; Fonseca, I
Current therapeutic approaches to primary CNS lymphoma	1-gen-2003	Ferreri, Ajm; Dell’Oro, S; Reni, M
The AP-1 transcription factor JunB promotes multiple myeloma cell proliferation, survival and drug resistance in the bone marrow microenvironment	1-gen-2016	Fan, ; Fengjuan, ; Vallet, ; Sonia, ; Bashari, ; Muhammad, Hasan; Jarahian, ; Mostafa, ; Morelli, ; Eugenio, ; Hose, ; Dirk, ; Bakiri, ; Latifa, ; Ball, ; Claudia, ; Glimm, ; Hanno, ; Sattler, ; Martin, ; Goldschmidt, ; Hartmut, ; Tonon, G; Tassone, ; Pierfrancesco, ; Wagner, ; Erwin, F.; Jager, ; Dirk, ; Podar, ; Klaus,
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets?	1-gen-2015	Brunetti, ; Russo, ; Scarpa, ; Santini, ; Reni, M; Bittoni, ; Azzariti, ; Aprile, ; Delcuratolo, ; Signorile, ; Gnoni, ; Palermo, ; Lorusso, ; Cascinu, ; Silvestris,
Awakening the Hippo co-activator YAP1, a mercurial cancer gene, in hematologic cancers	1-gen-2014	Cottini, ; Francesca, ; Anderson, ; Kenneth, C; Tonon, G
Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide	1-gen-2005	Brada, M; Ashley, S; Dowe, A; Gonsalves, A; Huchet, A; Pesce, G; Reni, M; Saran, F; Wharram, B; Wilkins, M; Wilkins, P
Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients	1-gen-2016	Calura, ; Enrica, ; Bisognin, ; Andrea, ; Manzoni, ; Martina, ; Todoerti, ; Katia, ; Taiana, ; Elisa, ; Sales, ; Gabriele, ; Morgan, ; Gareth, J.; Tonon, G; Amodio, ; Nicola, ; Tassone, ; Pierfrancesco, ; Neri, ; Antonino, ; Agnelli, ; Luca, ; Romualdi, ; Chiara, ; Bortoluzzi, ; Stefania,
Quality control by portal film analysis in radiotherapy for prostate cancer: A comparison between two different institutions and treatment techniques	1-gen-1998	Italia, C; Fiorino, C; Ciocca, M; Cattaneo, Gm; Montanaro, P; Bolognesi, A; Lanceni, A; Reni, M; Bonini, A; Modugno, A; Calandrino, R; Valdagni, R
The small- molecule VEGF- receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma	1-gen-2006	Podar, K; Tonon, G; Sattler, M; Catley, Lp; Tai, Yt; Yasui, H; Legouill, S; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc
Guidelines for the treatment of primary central nervous system lymphomas in immunocompetent patients	1-gen-2003	Ferreri, Ajm; Dell’Oro, S; Reni, M
Spectral karyotyping combined with locus-specific FISH simultaneously defines genes and chromosomes involved in chromosomal translocations.	1-gen-2000	Tonon, G; Roschke, A; Stover, K; Shou, Y; Kuehl, Wm; Kirsch, Ir
Neoadjuvant therapy in resectable pancreatic cancer: A critical review	1-gen-2013	Belli, C; Cereda, S; Anand, S; Reni, M
Karyotypic "state" as a potential determinant for anticancer drug discovery.	1-gen-2005	Roschke, Av; Lababidi, S; Tonon, G; Gehlhaus, Ks; Bussey, K; Weinstein, Jn; Kirsch, Ir
Primary CNS lymphomas prognosis	1-gen-2007	Ferreri, Ajm; Reni, M; Zucca, E; Cavalli, F
UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition	1-gen-2017	Ezponda, ; Teresa, ; Dupere-Richer, ; Daphne, ; Will, ; Christine, M.; Small, ; Eliza, C.; Varghese, ; Nobish, ; Patel, ; Tej, ; Nabet, ; Behnam, ; Popovic, ; Relja, ; Oyer, ; Jon, ; Bulic, ; Marinka, ; Zheng, ; Yupeng, ; Huang, ; Xiaoxiao, ; Shah, ; Mrinal, Y.; Maji, ; Sayantan, ; Riva, ; Alberto, ; Occhionorelli, ; Manuela, ; Tonon, G; Kelleher, ; Neil, ; Keats, ; Jonathan, ; Licht, ; Jonathan, D.
Second line treatment for primary central nervous system lymphoma	1-gen-1999	Reni, M; Ferreri, Ajm; Villa, E
Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells.	1-gen-2001	Greco, Nj; Tonon, G; Chen, W; Luo, X; Dalal, R; Jamieson, Ga
High resolution genomic profiles of human lung cancer.	1-gen-2005	Tonon, G; Wong, Kk; Maulik, G; Brennan, C; Feng, B; Zhang, Y; Khatry, Db; Protopopov, A; You, Mj; Aguirre, Aj; Martin, Es; Yang, Z; Ji, H; Chin, L; Depinho, Ra.
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications.	1-gen-2011	Podar, K; Zimmerhackl, A; Fulciniti, M; Tonon, G; Hainz, U; Tai, Yt; Vallet, S; Halama, N; Jäger, D; Olson, Dl; Sattler, M; Chauhan, D; Anderson, Kc.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 12.461 a 12.480 di 39.368

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext33603
open3370
reserved2288
partially open99
embargoed7
mixed1